Condition: Schizophrenia · Sponsor: Eli Lilly and Company
The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC for treatment of schizophrenia. The trial is divided into three periods as follows: Screening period will last approximately 1 month, treatment period will last a maximum of 12 months, and the follow up period will last approximately 2 months. The length of time of your study participation may last up to approximately 15 months.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Pillar Clinical Research- Little Rock | Little Rock, Arkansas, United States | Recruiting |
| Clinical Innovations, Inc. dba CITrials | Bellflower, California, United States | Recruiting |
| Collaborative Neuroscience Research, LLC | Garden Grove, California, United States | Recruiting |
| Catalina Research Institute, LLC | Montclair, California, United States | Not Yet Recruiting |
| Stanford University School of Medicine | Stanford, California, United States | Recruiting |
| Collaborative Neuroscience Research, LLC | Torrance, California, United States | Recruiting |
| Sunwise Clinical Research | Walnut Creek, California, United States | Recruiting |
| Institute of Living | Hartford, Connecticut, United States | Recruiting |
| Yale University School of Medicine | New Haven, Connecticut, United States | Recruiting |
| Magno Medical Research Group | Cooper City, Florida, United States | Recruiting |
| Innovative Clinical Research | Lauderhill, Florida, United States | Recruiting |
| Accel Research Sites - Maitland Clinical Research Unit | Maitland, Florida, United States | Recruiting |
+ 90 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07410507